Skip to main content
OpenTrials
Completed

NCT Number: NCT04545190

RibOSE - Glucose and Resistance Exercise Training

The aim of the study is to investigate the effects of ingesting glucose during five bouts of resistance exercise on muscle biological charateristics in m. vastus lateralis of moderately trained healthy individuals (20-45 years of age, n=20)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inland Norway University of Applied Sciences

Lillehammer, Norway

About this study

Muscular responses to resistance training vary extensively between humans, with many showing impaired growth. In such individuals, cellular plasticity is compromised, leading to reduced functional and health-beneficial outcomes of training. While this is likely due to a range of determinants, including epigenetic, genetic and physiological variables, recent studies suggest that it involves reduced ability to produce novel ribosomes in response to training. This eventually leads to less pronounced increases in protein synthesis, and thus decreased growth rates, and makes ribosomal content in muscle a potential proxy marker for training-associated muscle hypertrophy.

In a recent study, the investigators showed that increased resistance training volume was associated with more pronounced muscle growth, a trait that was associated with increased ribosomal biogenesis. Despite this, ~50 % of the participants did not exhibit true beneficial effects of increased training volume, which in turn coincided with reduced abilities to accumulate ribosomes. In such individuals, other means are likely necessary to circumvent the negative influence of genetic and epigenetic predispositions on muscle plasticity. Nutrient supplementation stand out as a potential therapy. However, at present, knowledge with regard to this perspective is limited to a selected few nutrients, with protein ingestion being the best studied potential adjuvant, for which adequate intake seems to be essential for achieving optimal muscle growth, potentially being interconnected with ribosomal synthesis. For other nutrients, such as glucose, little is know about their importance for muscle plasticity and ribosomal biogenesis.

In cell types such as cultivated kidney cells, exposure to high levels of glucose is an efficient mean to increase ribosomal biogenesis (and growth rates). This suggests that glucose is an important signaling molecule for increasing ribosomal production per se, perhaps acting as a ligand for signaling proteins or by acting to increase energy availability. In the human body (as opposed to cultured cells), glucose may also exert growth-stimulating effects by increasing insulin levels in blood. Overall, it thus seems plausible that glucose intake during resistance training may stimulate ribosomal biogenesis, in turn having beneficial effects for protein synthesis and muscle plasticity, perhaps acting in an additive manner to protein supplementation. At present, we do not know if this is the case, though studies have suggested that glucose ingestion during acute resistance training sessions may reduce training-induced muscle damage without affecting within-session work output (i.e. volume). This lack of knowledge is surprising given the long-standing appreciation of the beneficial effects of glucose intake for endurance performance, acting to delay muscular fatigue.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non-smoking
  • Moderately trained (i.e. having performed 2-8 resistance training sessions per 14 days for the last six months)

Exclusion criteria

  • Not able to understand Norwegian
  • Unstable cardiovascular disease
  • Illness or injury contradicting heavy strength training
  • Disabling musculoskeletal disease
  • Serious mental illness
  • Allergy to local anaesthesia
  • Impaired glucose tolerance

Treatment and study plan

Glucose

Dietary Supplement

To investigate the effects of glucose intake during resistance training on muscle biological adaptations

Primary outcomes

  1. Total RNA in muscle tissue

    Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)

    Total RNA content in m. vastus lateralis (ug per mg tissue)

Secondary outcomes

  1. Ribosomal RNA in skeletal muscle

    Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)

    Abundances of ribosomal RNA species in m. vastus lateralis measured using qPCR

  2. Protein in skeletal muscle

    Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)

    Abundances of protein species in m. vastus lateralis measured using Western blotting (e.g. ECM proteins)

  3. Gene expression in skeletal muscle

    Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)

    Abundances of mRNA species in m. vastus lateralis measured using qPCR

  4. Muscle fractional synthesis rate

    Time frame: Immediately after the intervention

    Protein synthesis rate measured using heavy water (deuterium) and chromatography/spectrometry

  5. Glucose in blood, after glucose/placebo intake

    Time frame: Immediately before glucose/placebo intake and 30 min, 45 min, 60 min and 195 min after initial glucose/placebo intake

    Glucose concentrations in blood (area under the curve), measured before and after intake of glucose/placebo on the two final days of the intervention (one day = glucose; one day = placebo)

  6. Glucose in blood (after protein intake)

    Time frame: Immediately before protein intake and 45 min and 90 min after protein intake

    Glucose concentrations in blood (area under the curve), measured before and after intake of protein on the two final days of the intervention

  7. Hormone concentrations in blood (after glucose/placebo intake)

    Time frame: Immediately before glucose/placebo intake and 30 min and 60 min after the initial glucose/placebo intake

    Abundances of insulin, c-peptide, testosterone, growth hormone, cortisol and inflammatory markers in blood (area under the curve), measured before and after intake of glucose/placebo on the two final days of the intervention (one day = glucose; one day = placebo)

  8. Hormone concentrations in blood (after protein intake)

    Time frame: Immediately before protein intake and 90 min after protein intake

    Abundances of insulin, c-peptide, testosterone, growth hormone, cortisol and inflammatory markers in blood, measured after intake of protein on the two final days of the intervention

  9. Unilateral lower body isokinetic muscle strength (during the intervention)

    Time frame: Before the intervention and after the second, fourth and sixth training session

    The ability of the knee extensors to exert maximal force during isokinetic movements (recovery/strength), measured before the intervention and at three time points during the intervention (~24 hours after training sessions)

  10. Unilateral lower body isokinetic muscle strength (last days of the intervention)

    Time frame: Before the last training session and 30 min, 120 min and 24 hours after the last training session

    The ability of the knee extensors to exert maximal force during isokinetic movements (recovery/strength), measured before and at three time points after the last two training sessions (one day = glucose; one day = placebo)

  11. Unilateral lower body isometric muscle strength (during the intervention)

    Time frame: Before the intervention and after the second, fourth and sixth training session

    The ability of the knee extensors to exert maximal force during isometric actions (recovery/strength), measured before the intervention and at three time points during the intervention (~24 hours after training sessions)

  12. Unilateral lower body isometric muscle strength (last days of the intervention)

    Time frame: Before the last training session and 30 min, 120 min and 24 hours after the last training session

    The ability of the knee extensors to exert maximal force during isometric actions (recovery/strength), measured before and at three time points after the last two training sessions (one day = glucose; one day = placebo)

  13. Perceived muscle soreness (during the intervention)

    Time frame: Before the intervention and 24 hours after each training session

    Muscular soreness measured before the intervention and at three time points during the intervention (~24 hours after training sessions) using a VAS-scale from 0 to 10 (0 = no soreness; 10 = maximal soreness)

  14. Perceived feeling of the legs (during the intervention)

    Time frame: 30 min after each training session

    Feeling of the legs measured immediately after each training session using a 9-point scale (1 = very very good, 9 = very very heavy)

Other outcomes

  1. Training diary

    Time frame: During each training session of the intervention

    Training volume (total kg lifted) during each day of the intervention

  2. Body mass composition

    Time frame: Prior to the intervention

    Body mass composition measured using DXA

  3. Dietary registration

    Time frame: During each day of the intervention

    Nutritional intake during each day of the intervention, tracked using MyFitnessPal

  4. Unilateral lower body maximal strength

    Time frame: Before the intervention

    The ability of muscles of the lower body to exert maximal force during dynamic movements

  5. Blind test glucose vs placebo comparators

    Time frame: Immediately after the intervention

    The ability to discriminate between glucose and placebo beverages, tested after the training intervention using a blinded randomized design: each participant will ingest six beverages (3 x glucose and 3 x placebo) and will be asked to identify theam as either glucose or placebo. The "ability to discriminate" will be determined based on analyses of the full study population

  6. Deuterium in spit

    Time frame: On each day of the intervention

    Deuterium levels in spit on each day during the intervention measured using chromatography/spectrometry (sampled prior to each training session)

  7. Fasting blood glucose

    Time frame: Before the intervention and immediately after the intervention

    Fasting blood glucose measured in serum, measured before the intervention and prior to training on the last two days of the intervention

Sponsors and collaborators

Lead sponsor

Inland Norway University of Applied Sciences

Other

Registry information

Official study title

RibOSE - Effects of Glucose Ingestion During Resistance Exercise Training on Ribosomal Biogenesis in Skeletal Muscle

Acronym: RibOSE

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Sep 10, 2020
Registry last updated
Feb 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.